PET-guided Radiotherapy for Patients With Small Cell Lung Cancer.
Recruiting · NCT06247163 · Observational (researchers observe without assigning treatment)
View the official record on ClinicalTrials.gov →Interventions studied
PET based Raditherapy boost
What this trial is about
There is a prospective risk-adapted evaluation of the optimal dose of radiotherapy for definitive radiotherapy of locally advanced small cell lung cancer within the corridor recommended as standard therapy according to the current interdisciplinary S3 guideline of the German Cancer Society/Cancer Aid/AWMF
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Histopathologic confirmation
- Limited disease
Exclusion criteria
- Other histology than small cell lung cancer
- Further tumor diagnosis
- ECOG 3 or worse
- Extensive disease
- stage IV
Where it is running
1 location listed.
- University Hospital Essen - Essen, Germany